There is a need of some bedside noninvasive, safe method of detection. OPTIC NERVE SHEATH DIAMETER measured by ultrasound can be an important device for prediction of raised ICP with the added

benefit of it being a bedside/ point of care test.

OPTIC NERVE SHEATH DIAMETER has been utilized in various neurological complications. Pré-eclampsia is a complex condition which affects the multiple organ systems, including the central nervous system.

Based on this background, this study is designed to study the pregnancy outcome in women with preeclampsia using optic nerve sheath diameter. 

AIM(S) & OBJECTIVE(S)

AIM: To predict the pregnancy outcomes in women with preeclampsia using optic nerve sheath diameter

OBJECTIVE:

To measure and correlate the optic nerve sheath diameter with the pregnancy outcome in women with preeclampsia.

This study will be conducted in the Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi.

Type of study: Prospective observational study

Duration of study:18months

Study setting: Department of Obstetrics and Gynecology, and Department of Radiodiagnosis

     Vardhman Mahavir Medical College and Safdarjung Hospital,

      New Delhi

Study population: All antenatal women meeting the eligibility criteria Inclusion criteria:

1. Singleton Pregnancy with period of gestation>28 weeks with preeclampsia

Exclusion criteria:

1. Known neurological disorders (eg epilepsy, intracranial space-occupying lesion, trauma, hydrocephalus)

2. Ocular disease affecting optic nerve (optic neuritis, orbital cellulitis, glaucoma)

3. Chronic renal disease / chronic liver disease not related to pre-eclampsia

4. Long-term Magnesium therapy or diuretics

5. Multiple pregnancy

6. Fetal anomalies

METHODOLOGY

This study titled “PREDICTION OF PREGNANCY OUTCOME IN PRE ECLAMPSIA

USING OPTIC NERVE SHEATH DIAMETER” is a prospective observational study that will be performed on 200 participants over 18 months duration in the Dept of Obstetrics and Gynaecology, VMMC and SJH, New Delhi. All pregnant women will be screened for eligibility as per inclusion and exclusion criteria of the study. Informed consent will be taken. Data collection as per the study performa will be done, the management will be done as per the departmental protocol.

Measurement of –All enrolled women will be followed and pregnancy outcome will be noted in terms of adverse materno-fetal outcomes.

Definition of adverse outcome:

1-Maternal:

• Progression to eclampsia

• ICU admission

• Abruption

• Neurological complications

• Maternal mortality

 2-Fetal:

• Preterm birth

• Perinatal mortality

Optic nerve sheath diameter measurement will be done once the patient is planned for termination of pregnancy using ultrasonography machine: ESAOTE S.P. A model: MylabX75 with linear probe of frequency between 4-15MHz.The patients will be placed in the supine position, with their eyes closed and head in the neutral position elevated to 30 degrees. The transducer will be gently placed on the temporal region of the upper eyelid and slightly tilted caudally and medially until an image of the orbit was obtained on the axial axis, showing the entry point of the optic nerve into the ocular globe. The image will be taken until cross-sectional measurement of the optic nerve sheath 3 mm from its entry into the ocular globe. The procedure will be performed three times on each eye, with the final value recorded in millimeters corresponding to the mean of all the measurements. All women will be followed till delivery and pregnancy outcome will be recorded as defined above.

OUTCOMES:

1. Correlation of pregnancy outcome in preeclampsia with optic nerve sheath diameter.

2. Sensitivity, specificity, predictive value and cut-off of optic nerve sheath diameter for predicting adverse pregnancy outcomes in preeclampsia.